Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency
Immunology·MeSH: Severe combined immunodeficiency due to adenosine deaminase deficiency
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency?
There are 1 clinical trial targeting Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency tracked by BioSniper.
What is the prevalence of Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency?
The estimated prevalence of Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency is approximately 0.5 per 100,000 population.
Deep-dive into Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis